Your search for esrd returned 14 results

Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.

MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.

Camizestrant improved progression-free survival vs fulvestrant in postmenopausal patients with ER+, HER2- advanced breast cancer.

In patients whose tumors had ESR1 mutations, elacestrant reduced the risk of progression or death by 45%.

The duration of prior treatment with a CDK4/6 inhibitor appears to impact progression-free survival with elacestrant in ER+/HER2- metastatic breast cancer.

Plasma D-dimer had comparable accuracy to CRP, ESR, fibrinogen for diagnosing periprosthetic joint infection in patients with revision hip or knee arthroplasty

Regular users may be at risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy

Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.

Study findings do not support initiation of uric acid-lowering therapy to prevent CKD.

The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.